Li; Qingyi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Qingyi.The latest application filed is for "macrocyclic azolopyridine derivatives as eed and prc2 modulators".

Company Profile

3.10.14

Li; Qingyi - Somerville MA
LI; Qingyi - Suqian CN
Li; Qingyi - Jiangsu CN
LI; Qingyi - Changzhou Jiangsu
Li; Qingyi - Jiangshu N/A CN
Li; Qingyi - Lexington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
4'-phosphate analogs and oligonucleotides comprising the same Grant 11,414,659 - Wang , et al. August 16, 2	2022-08-16
Macrocyclic Azolopyridine Derivatives As Eed And Prc2 Modulators App 20220160686 - Efremov; Ivan Viktorovich ; et al.	2022-05-26
Halogen-substituted Compound, Preparation Method Therefor, And Use Thereof App 20220089546 - WANG; Mingchun ; et al.	2022-03-24
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Grant 10,973,805 - Efremov , et al. April 13, 2	2021-04-13
Macrocyclic Azolopyridine Derivatives As Eed And Prc2 Modulators App 20200360353 - EFREMOV; Ivan Viktorovich ; et al.	2020-11-19
Method for the preparation of 3-fluoroalkyl-1-methylpyrazol-4-carboxylic acid Grant 10,457,645 - Wang , et al. Oc	2019-10-29
Inhibiting the transient receptor potential A1 ion channel Grant 10,428,072 - Lippa , et al. October 1, 2	2019-10-01
4'-phosphate Analogs And Oligonucleotides Comprising The Same App 20190177729 - Wang; Weimin ; et al.	2019-06-13
Method For The Preparation Of 3-fluoroalkyl-1-methylpyrazol-4-carboxylic Acid App 20180273486 - WANG; Mingchun ; et al.	2018-09-27
Inhibiting The Transient Receptor Potential A1 Ion Channel App 20180230149 - Lippa; Blaise S. ; et al.	2018-08-16
Oral Pharmaceutical Composition For Increasing Hypoxia Tolerance App 20180117036 - XIE; Hebing ; et al.	2018-05-03
Inhibiting The Transient Receptor Potential A1 Ion Channel App 20170050966 - Lippa; Blaise S. ; et al.	2017-02-23
Antihypoxic pharmaceutical composition and application thereof Grant 9,421,181 - Xie , et al. August 23, 2	2016-08-23
Inhibiting the transient receptor potential A1 ion channel Grant 9,394,308 - Li , et al. July 19, 2	2016-07-19
Oral Pharmaceutical Composition For Increasing Hypoxia Tolerance App 20160106741 - XIE; Hebing ; et al.	2016-04-21
Antihypoxic Pharmaceutical Composition And Application Thereof App 20160081966 - XIE; Hebing ; et al.	2016-03-24
Preparation method of high-purity L-carnitine Grant 9,096,493 - Gu , et al. August 4, 2	2015-08-04
Inhibiting The Transient Receptor Potential A1 Ion Channel App 20140206650 - Lippa; Blaise S. ; et al.	2014-07-24
Inhibiting Trpa1 For The Treatment Of Asthma App 20140158116 - Chong; Jayhong A. ; et al.	2014-06-12
Preparation and its use of derivatization reagent for detecting L-carnitine or D-carnitine Grant 8,709,819 - Gu , et al. April 29, 2	2014-04-29
Preparation And Its Use Of Derivatization Reagent For Detecting L-carnitine Or D-carnitine App 20110281293 - Gu; Shuhua ; et al.	2011-11-17
Preparation Method Of High-purity L-carnitine App 20110263897 - Gu; Shuhua ; et al.	2011-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.